Medicamen Biotec

{
  "main_header": {
    "sid": 770569,
    "name": "Medicamen Biotec",
    "stock_name": "Medicamen Biotec",
    "full_name": "Medicamen Biotech Ltd",
    "name_url": "stocks-analysis/medicamen-biotec",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "292.55",
    "chg": 12.45,
    "chgp": "4.44%",
    "dir": 1,
    "prev_price": "280.10",
    "mcapval": "383.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531146,
    "symbol": "MEDICAMEQ",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE646B01010",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "42.27 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medicamen-biotec-770569-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Medicamen Biotech Ltd Upgraded to Sell Amid Mixed Technicals and Weak Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-upgraded-to-sell-amid-mixed-technicals-and-weak-financials-3977087",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicamenBiotec_mojoScore_3977087.png",
        "date": "2026-05-06 08:10:38",
        "description": "Medicamen Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The change, effective from 5 May 2026, is driven primarily by an improvement in technical indicators, while valuation and financial trends continue to present a mixed picture for investors."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3975776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/MedicamenBiotec_mojoScore_3975776.png",
        "date": "2026-05-05 10:10:17",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3960643",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3960643.png",
        "date": "2026-04-24 10:10:31",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Medicamen Biotech Ltd Valuation Shifts Signal Changing Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-valuation-shifts-signal-changing-market-sentiment-3958294",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_valuationdot_3958294.png",
        "date": "2026-04-23 08:00:58",
        "description": "Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a recent uptick in its share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside subdued returns on capital, have raised concerns among investors and analysts alike."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3944618",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3944618.png",
        "date": "2026-04-13 10:10:32",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 April 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects."
      },
      {
        "title": "Medicamen Biotech Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medicamen-biotech-ltd-is-rated-strong-sell-3930156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MedicamenBiotec_mojoScore_3930156.png",
        "date": "2026-04-02 10:10:29",
        "description": "Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 225 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-amid-continued-downtrend-3924557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3924557.png",
        "date": "2026-03-30 11:46:12",
        "description": "For the second consecutive session, Medicamen Biotech Ltd has seen its share price slide further, hitting a fresh 52-week low of Rs 225 on 30 Mar 2026. This decline extends a recent losing streak that has erased nearly 10% of its value over two days, underscoring persistent selling pressure amid a challenging market backdrop."
      },
      {
        "title": "Medicamen Biotech Ltd Falls to 52-Week Low of Rs 234.35 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-falls-to-52-week-low-amid-continued-downtrend-3920353",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3920353.png",
        "date": "2026-03-27 15:55:50",
        "description": "A sharp decline in Medicamen Biotech Ltd has pushed the stock to a fresh 52-week low of Rs 234.35 on 27 Mar 2026, marking a significant 47.95% drop over the past year. This downturn comes amid broader market weakness and persistent underperformance relative to benchmarks and peers."
      },
      {
        "title": "Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medicamen-biotech-ltd-stock-falls-to-52-week-low-of-rs24325-3907225",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MedicamenBiotec_priceRelatedfactors_3907225.png",
        "date": "2026-03-23 11:00:31",
        "description": "For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, hitting a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector downturn but marks a significant underperformance relative to the market and peers."
      }
    ],
    "total": 6235,
    "sid": "770569",
    "stock_news_url": "https://www.marketsmojo.com/news/medicamen-biotech-770569"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "16-Apr-2026",
      "details": "Compliance Certifcate under Reg 74 (5) of SEBI (DP) Regulation 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Intimation Regarding Incorrect Event Disply On NSDL Portal",
      "datetime": "06-Apr-2026",
      "details": "Intimation regarding Incorrent Event Display on NSDL Portal",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "30-Mar-2026",
      "details": "Intimation of Closure of Trading Window - March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medicamen Biotech Ltd has declared <strong>10%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medicamen Biotech Ltd Upgraded to Sell Amid Mixed Technicals and Weak Financials

2026-05-06 08:10:38

Medicamen Biotech Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced shift in its technical outlook despite ongoing financial challenges. The change, effective from 5 May 2026, is driven primarily by an improvement in technical indicators, while valuation and financial trends continue to present a mixed picture for investors.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-05-05 10:10:17

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 May 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-24 10:10:31

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Medicamen Biotech Ltd Valuation Shifts Signal Changing Market Sentiment

2026-04-23 08:00:58

Medicamen Biotech Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. Despite a recent uptick in its share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, alongside subdued returns on capital, have raised concerns among investors and analysts alike.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-13 10:10:32

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 February 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the company’s current position as of 13 April 2026, providing investors with the latest comprehensive view of the stock’s performance and prospects.

Read full news article

Medicamen Biotech Ltd is Rated Strong Sell

2026-04-02 10:10:29

Medicamen Biotech Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and technical outlook.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 225 as Sell-Off Deepens

2026-03-30 11:46:12

For the second consecutive session, Medicamen Biotech Ltd has seen its share price slide further, hitting a fresh 52-week low of Rs 225 on 30 Mar 2026. This decline extends a recent losing streak that has erased nearly 10% of its value over two days, underscoring persistent selling pressure amid a challenging market backdrop.

Read full news article

Medicamen Biotech Ltd Falls to 52-Week Low of Rs 234.35 as Sell-Off Deepens

2026-03-27 15:55:50

A sharp decline in Medicamen Biotech Ltd has pushed the stock to a fresh 52-week low of Rs 234.35 on 27 Mar 2026, marking a significant 47.95% drop over the past year. This downturn comes amid broader market weakness and persistent underperformance relative to benchmarks and peers.

Read full news article

Five Consecutive Losses Push Medicamen Biotech Ltd to a New 52-Week Low

2026-03-23 11:00:31

For the fifth consecutive session, Medicamen Biotech Ltd has closed lower, hitting a fresh 52-week low of Rs 243.25 on 23 Mar 2026. This decline comes amid a broader sector downturn but marks a significant underperformance relative to the market and peers.

Read full news article

View All News